Shenzhen Edge Medical Statistics
Total Valuation
HKG:2675 has a market cap or net worth of HKD 23.03 billion. The enterprise value is 21.93 billion.
| Market Cap | 23.03B |
| Enterprise Value | 21.93B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2675 has 387.72 million shares outstanding.
| Current Share Class | 323.60M |
| Shares Outstanding | 387.72M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.96% |
| Owned by Institutions (%) | 19.78% |
| Float | 91.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 75.30 |
| PB Ratio | 17.74 |
| P/TBV Ratio | 17.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -114.36 |
| EV / Sales | 71.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -104.25 |
Financial Position
The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.62 |
| Quick Ratio | 10.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -338.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -12.90% |
| Return on Capital Employed (ROCE) | -19.58% |
| Revenue Per Employee | 2.04M |
| Profits Per Employee | -1.28M |
| Employee Count | 150 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HKG:2675 has paid 24,107 in taxes.
| Income Tax | 24,107 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,779,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2675 had revenue of HKD 305.87 million and -191.79 million in losses. Loss per share was -0.53.
| Revenue | 305.87M |
| Gross Profit | 168.37M |
| Operating Income | -257.63M |
| Pretax Income | -191.77M |
| Net Income | -191.79M |
| EBITDA | -236.33M |
| EBIT | -257.63M |
| Loss Per Share | -0.53 |
Balance Sheet
The company has 1.11 billion in cash and 14.93 million in debt, with a net cash position of 1.10 billion or 2.83 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 14.93M |
| Net Cash | 1.10B |
| Net Cash Per Share | 2.83 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 3.61 |
| Working Capital | 1.23B |
Cash Flow
In the last 12 months, operating cash flow was -206.08 million and capital expenditures -4.32 million, giving a free cash flow of -210.40 million.
| Operating Cash Flow | -206.08M |
| Capital Expenditures | -4.32M |
| Free Cash Flow | -210.40M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 55.05%, with operating and profit margins of -84.23% and -62.70%.
| Gross Margin | 55.05% |
| Operating Margin | -84.23% |
| Pretax Margin | -62.70% |
| Profit Margin | -62.70% |
| EBITDA Margin | -77.26% |
| EBIT Margin | -84.23% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2675 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.83% |
| FCF Yield | -0.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2675 has an Altman Z-Score of -0.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.22 |
| Piotroski F-Score | 1 |